John Nosenzo - Feb 10, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: CHIEF COMMERCIAL OFFICER
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: Feb 10, 2022
Transactions value $: $311,760
Form type: 4
Date filed: 2/14/2022, 07:41 PM
Previous filing: Jun 4, 2021
Next filing: Feb 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise		+66.1K	+13227.8%		66.6K	Feb 10, 2022	Direct	F1
transaction	BVS	Class A Common Stock	Tax liability	$312K	+24.2K	+132.78%	$12.88	42.4K	Feb 10, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Phantom Profit Units	Options Exercise	$0	-66.1K	-100%	$0.00^*	0	Feb 10, 2022	Class A Common Stock	66.1K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.